Stay updated on Nivolumab & Brentuximab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Brentuximab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Brentuximab in Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:28:16.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision metadata updated to v3.5.0 (added) and v3.4.3 removed. This is a page version update and does not alter any study details.
    Difference
    0.0%
    Check dated 2026-03-19T05:33:18.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed. This is a minor version-label update and does not alter page content or functionality.
    Difference
    0.0%
    Check dated 2026-03-12T02:22:43.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Administrative updates show a new site revision (v3.4.2) and removal of the previous funding/operating-status notice; these changes do not affect the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:21:22.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added a government funding status notice and updated the page to revision 3.4.1, replacing revision 3.4.0.
    Difference
    0.3%
    Check dated 2026-02-04T10:38:29.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated QC labels, including a new 'Revision: v3.4.0'. Removed older QC label variants like 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:30:12.000Z thumbnail image

Stay in the know with updates to Nivolumab & Brentuximab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Brentuximab in Lymphoma Clinical Trial page.